CASTAGNA, Annalisa
 Distribuzione geografica
Continente #
NA - Nord America 7.160
EU - Europa 6.327
AS - Asia 4.409
SA - Sud America 630
AF - Africa 144
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.687
Nazione #
US - Stati Uniti d'America 7.030
RU - Federazione Russa 2.665
SG - Singapore 1.762
CN - Cina 1.275
GB - Regno Unito 1.094
IT - Italia 518
DE - Germania 513
BR - Brasile 487
VN - Vietnam 440
SE - Svezia 357
HK - Hong Kong 336
FR - Francia 304
IE - Irlanda 262
FI - Finlandia 257
KR - Corea 136
JP - Giappone 101
IN - India 84
CA - Canada 75
UA - Ucraina 74
AR - Argentina 70
NL - Olanda 52
BE - Belgio 45
TR - Turchia 39
ID - Indonesia 38
ZA - Sudafrica 37
PL - Polonia 34
IQ - Iraq 33
MX - Messico 33
NG - Nigeria 33
BD - Bangladesh 29
ES - Italia 24
AT - Austria 17
CL - Cile 17
LT - Lituania 16
PK - Pakistan 16
VE - Venezuela 16
RO - Romania 14
AU - Australia 12
CH - Svizzera 12
CO - Colombia 12
EG - Egitto 11
IL - Israele 11
KE - Kenya 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
MA - Marocco 10
AE - Emirati Arabi Uniti 8
EC - Ecuador 8
HR - Croazia 8
IR - Iran 8
MY - Malesia 8
DZ - Algeria 7
GR - Grecia 7
NP - Nepal 7
PH - Filippine 7
PT - Portogallo 7
TG - Togo 7
TN - Tunisia 7
BJ - Benin 6
CZ - Repubblica Ceca 6
UY - Uruguay 6
BG - Bulgaria 5
BO - Bolivia 5
JM - Giamaica 5
LB - Libano 5
LV - Lettonia 5
PE - Perù 5
TH - Thailandia 5
AZ - Azerbaigian 4
BH - Bahrain 4
DK - Danimarca 4
EE - Estonia 4
ET - Etiopia 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
RS - Serbia 4
TT - Trinidad e Tobago 4
HN - Honduras 3
HU - Ungheria 3
NO - Norvegia 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
LK - Sri Lanka 2
MD - Moldavia 2
OM - Oman 2
PY - Paraguay 2
SI - Slovenia 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
Totale 18.661
Città #
Singapore 1.002
Moscow 922
Southend 856
Ashburn 836
Dallas 796
Chandler 741
San Jose 601
Jacksonville 507
Ann Arbor 359
Hong Kong 329
Woodbridge 307
Verona 265
Dublin 262
Houston 219
Beijing 211
New York 198
The Dalles 196
Ho Chi Minh City 141
Los Angeles 121
Wilmington 119
Munich 117
Lawrence 102
Princeton 102
Tokyo 95
Jinan 85
Hanoi 82
Nanjing 77
Boardman 76
Helsinki 72
Shenyang 70
Santa Clara 59
Buffalo 53
São Paulo 53
Council Bluffs 50
Redondo Beach 49
Brussels 45
Hebei 42
Columbus 41
Tianjin 38
Turku 38
Orem 37
Redmond 35
London 34
Sindelfingen 34
Lancaster 33
Milan 33
Montreal 33
Zhengzhou 32
Abuja 31
Changsha 31
Haikou 29
Nanchang 29
Johannesburg 28
Seattle 27
Jiaxing 25
Rio de Janeiro 25
Warsaw 25
Brooklyn 24
Denver 23
Guangzhou 23
Hangzhou 23
Chennai 21
Falkenstein 21
Frankfurt am Main 21
Jakarta 21
Phoenix 21
Seoul 21
Toronto 21
Dong Ket 20
Haiphong 20
Taiyuan 20
Amsterdam 19
Padova 19
Atlanta 18
Ningbo 18
Taizhou 17
Chicago 16
Da Nang 16
Poplar 16
Stockholm 16
Falls Church 15
Norwalk 15
Vienna 15
Hải Dương 14
Nürnberg 14
Shanghai 14
Fuzhou 13
Mumbai 13
San Francisco 13
Ankara 12
Barnet 12
Buenos Aires 12
Fairfield 12
Manchester 12
Mexico City 12
Washington 12
Zurich 12
Baghdad 11
Boydton 11
Dearborn 11
Totale 11.565
Nome #
Epigenetic Regulation Through Histone Deacetylation: Implications and Therapeutic Potential in Hepatocellular Carcinoma 337
Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism 314
Apolipoprotein -CIII glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 248
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma 223
Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodium. 216
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin 213
ApoCIII glycoforms determination and proteomic analysis in plasma of coronary patients with different ApoCIII levels . 208
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 207
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 206
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 205
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 205
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 204
Hepcidin and DNA promoter methylation in hepatocellular carcinoma 203
Isoelectric beads for proteome pre-fractionation.II :experimental evaluation in a multicompartment electroyzer 196
Identification of new BMP6 pro-peptide mutations in patients with iron overload 196
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 196
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 195
Immunoaffinity reactors for prion protein qualitative analysis 194
miRNAs purification and analysis from urinary exosomes. 193
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 191
The proteome: anno Domini 2002 190
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 188
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 188
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 188
Apolipoprotein C-III glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 188
"Exploring the hidden human urinary proteome via ligand library beads" 186
Altered paraoxonase expression in patients with genetic haemochromatosis. 186
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 184
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 183
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII 180
A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. 175
NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism. 174
Epigenetics regulation of HSD11B2 gene by promoter methylation in glucocorticoid-treated patients 174
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 173
Female urinary proteomics: New insight into exogenous and physiological hormone-dependent changes. 172
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 172
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 171
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 170
“Proteomics approaches for studying chemoresistance in cancer” 170
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up 169
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 168
pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease 167
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 166
Surface plasmon resonance based on molecularly imprinted nanoparticles for the picomolar detection of the iron regulating hormone Hepcidin-25 165
How to bring the "unseen" proteome to the limelight via electrophoretic pre-fractionation techniques 165
Detection of urinary exosomal HSD11B2 mRNA expression: a useful novel tool for the diagnostic approach of dysfunctional 11β-HSD2-related hypertension 165
Monocyte/macrophage proteomics: recent findings and biomedical applications. 164
"Prefractionation of urinary proteins" 163
Increased plasma thrombin potential is associated with stable coronary artery disease: An angiographically-controlled study 163
Plasma proteomic analysis of patients with Coronary Artery Disease with different levels of apolipoprotein CIII 163
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII 163
Prefractionation techniques in proteome analysis: the mining tools of the third millennium. 162
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 162
Amphoteric,buffering chromatographic beads for proteome prefractionation.I :theoretical model 161
Epigenetic control of 11-beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension 161
Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome 161
Murine macrophages response to iron 159
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 157
High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics 156
Serum Uric Acid Levels, but Not rs7442295 Polymorphism of SCL2A9 Gene, Predict Mortality in Clinically Stable Coronary Artery Disease 155
Iron metabolism in Murine Macrophages: a proteomic insight. 153
Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate 153
Urinary prostasin: a candidate marker of ENaC activation in humans:study of preliminary feasibility 149
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 148
Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease 147
Epigenetic control of hydroxysteroid (11-beta) dehydrogenase 2 gene is related to human hypertension 146
The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease 144
Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity 142
Optimizing the purification and analysis of miRNAs from urinary exosomes. 141
Myristic acid induces proteomic and secretomic changes associated with steatosis, cytoskeleton remodeling, endoplasmic reticulum stress, protein turnover and exosome release in HepG2 cells 141
“Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches” 140
Urinary Metabolic Signature of Primary Aldosteronism: Gender and Subtype-Specific Alterations 140
Modern iron replacement therapy: clinical and pathophysiological insights 139
Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation 137
Plasma Proteome Profiles of Stable CAD Patients Stratified According to Total Apo C-III Levels 136
High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin 136
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism 135
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 134
Imprinted polymers for the recognition/quantitation of the peptide hormone hepcidin 133
Associations between higher plasma ferritin and hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory study 132
Reduced serum hepcidin levels in patients with chronic hepatitis C 132
Carbamylation of proteins in 2-D electrophoresis--myth or reality? 131
Hepcidin assay in serum by SELDI-TOF-MS and other approaches 131
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 131
Proteomic analysis of urinary extracellular vesicles highlights specific signatures for patients with primary aldosteronism 129
null 129
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 129
“Conventional isoelectric focusing in gel slabs and capillaries and immobilized pH gradients” 127
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 126
Myristic acid plasma levels are strongly correlated with triglyceride and Apolipoprotein C-III plasma concentration in a cohort of subjects with or without coronary artery disease 125
Identification of Early Biomarkers of Mortality in COVID-19 Hospitalized Patients: A LASSO-Based Cox and Logistic Approach 124
Beta-elimination: an unexpected artefact in proteome analysis. 121
Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material 121
Circadian exosomal expression of renal thiazide-sensitive NaCl cotransporter (NCC) and prostasin in healthy individuals 118
Hormone-Dependent Changes in Female Urinary Proteome 117
Hepcidin resistance in dysmetabolic iron overload 115
Urinary extracellular vesicle mRNA analysis of sodium chloride cotransporter in hypertensive patients under different conditions 115
Reducing protein concentration range of biological samples using solid-phase ligand libraries 113
Treatment options for anemia in the elderly 113
Activated Factor VII–Antithrombin Complex, a Biomarker of Tissue Factor-Related Pathways in Different Clinical Settings: A Narrative Review from Cardiovascular Diseases to Cancer 110
Totale 16.460
Categoria #
all - tutte 58.801
article - articoli 45.804
book - libri 0
conference - conferenze 11.640
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.357
Totale 117.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021164 0 0 0 0 0 0 0 0 0 25 91 48
2021/2022812 62 256 8 63 25 25 7 37 43 18 75 193
2022/20232.027 120 231 167 335 199 474 31 127 261 12 36 34
2023/20241.075 43 88 72 106 117 209 21 69 12 29 189 120
2024/20252.503 125 183 123 427 97 94 128 86 344 160 209 527
2025/20268.668 562 407 887 1.525 2.285 574 854 445 631 498 0 0
Totale 18.846